Log in to save to my catalogue

A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation a...

A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7183235

A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination

About this item

Full title

A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2020-04, Vol.117 (16), p.9082-9093

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Current multiple sclerosis (MS) medications are mainly immunomodulatory, having little or no effect on neuroregeneration of damaged central nervous system (CNS) tissue; they are thus primarily effective at the acute stage of disease, but much less so at the chronic stage. An MS therapy that has both immunomodulatory and neuroregenerative effectswou...

Alternative Titles

Full title

A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7183235

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7183235

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.2000208117

How to access this item